Cleared Traditional

K233006 - MyndMove

K233006 is an FDA 510(k) clearance for MyndMove, manufactured by Myndtec, Inc.. The device is a Class 2 Physical Medicine device with product code GZI cleared through the Traditional 510(k) pathway after a 277-day FDA review.

K233006 · Myndtec, Inc. · Physical Medicine device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2024
Decision
277d
Days
Class 2
Risk

K233006 is an FDA 510(k) clearance for the MyndMove, MyndMove 2.0. Classified as Stimulator, Neuromuscular, External Functional (product code GZI), Class II - Special Controls.

Submitted by Myndtec, Inc. (Mississauga, CA). The FDA issued a Cleared decision on June 25, 2024 after a review of 277 days - an extended review cycle.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 882.5810 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.

View all Myndtec, Inc. devices

FDA 510(k) Submission Details - K233006

510(k) Number K233006 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 22, 2023
Decision Date June 25, 2024
Days to Decision 277 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
162d slower than avg
Panel avg: 115d · This submission: 277d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZI Device Classification - Class 2, Special Controls

Product Code GZI Stimulator, Neuromuscular, External Functional
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5810
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Physical Medicine devices follow this clearance model.

Regulatory Peers - GZI Stimulator, Neuromuscular, External Functional

All 19
Devices cleared under the same product code (GZI) and FDA review panel - the closest regulatory comparables to K233006.
Synchrony (20-3000)
K242704 · Synapse Biomedical, Inc. · Jun 2025
CIONIC NEURAL SLEEVE (NS-200)
K243828 · Cionic, Inc. · May 2025
Neuvotion NeuStim NN-01
K240632 · Neuvotion, Inc. · Nov 2024
EvoWalk 1.0 System
K230997 · Evolution Devices, Inc. · Dec 2023
Cionic Neural Sleeve NS-100
K221823 · Cionic · Jul 2022
MyoCycle MC-2 (Home / Home + / Pro / Pro +)
K213925 · Myolyn, LLC · Apr 2022